SCHEDULE 13D/A: Saba Capital Reduces Stake in BlackRock Capital Allocation Term Trust, Discloses Recent Share Sales

Saba Capital Management, L.P. and its affiliates have filed an amended Schedule 13D, revealing a reduction in their beneficial ownership of BlackRock Capital Allocation Term Trust to 9.64% following a series of open market share sales.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") have filed Amendment No. 17 to their Schedule 13D regarding their beneficial ownership in BlackRock Capital Allocation Term Trust.
• The Reporting Persons collectively beneficially own 10,098,050 common shares (Saba Capital, Saba GP) and 10,098,051 common shares (Boaz R. Weinstein) of BlackRock Capital Allocation Term Trust.
• This ownership represents 9.64% of the issuer's common stock, calculated based on 104,775,271 shares outstanding as of May 19, 2025.
• Funds for the acquisition of these shares, totaling approximately $147,943,670, were derived from investor subscription proceeds, capital appreciation, and ordinary course margin account borrowings.
• Between May 8, 2025, and May 29, 2025, Saba Capital Management, L.P. executed multiple 'Sell' transactions in the open market, totaling 888,712 shares at prices ranging from $14.62 to $15.27 per share.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the disclosure of significant share sales by a major beneficial owner, which can be interpreted as a lack of confidence or a strategic divestment.

Negatives

• The Reporting Persons, a significant beneficial owner, have engaged in a series of share sales, indicating a reduction in their stake in BlackRock Capital Allocation Term Trust.
• The sale of 888,712 shares over a short period by a major investor could be perceived as a negative signal by the market regarding the issuer's prospects or valuation.

Risks

• The use of margin account borrowings for share purchases introduces financial leverage and potential risk if the value of the pledged collateral declines.

Future Outlook

The document does not provide explicit forward-looking statements or guidance from the issuer or the reporting persons regarding future performance or strategic direction.

Industry Context

This filing is typical for activist investors or large institutional shareholders disclosing changes in their significant stakes in publicly traded companies, often closed-end funds. Saba Capital Management is known for its investment strategies in this sector, and such disclosures provide transparency into their portfolio adjustments.

Legal Proceedings

• The Reporting Persons have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) in the last five years.
• The Reporting Persons have not been a party to a civil proceeding that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws, or finding any violation with respect to such laws, in the last five years.

Stakeholder Impact

• Shareholders: The reduction in beneficial ownership by a significant investor like Saba Capital could influence investor sentiment and potentially the share price.
• Creditors: The use of margin accounts for share purchases implies that positions are pledged as collateral, which could affect creditors if debit balances exist and collateral value declines.

Key Dates

Keywords

Schedule 13D, Beneficial Ownership, Investment Fund, Share Sales, BlackRock Capital Allocation Term Trust, Saba Capital Management, Closed-End Fund, SEC Filing, Institutional Investor